Harrow, Inc. (HROW) income statement
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$32.16+2.64 (+8.94%)
Close on Nov 18, 2026Market cap $1.21BP/E –Yield –
Harrow, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 73.3%
- Operating margin
- -1.0%
- Net margin
- -13.5%
- Return on equity, FY2025
- -8.4%
Financial strength
- Current ratio
- 2.24
- Debt to equity
- 19.24
- Debt to assets
- 70.1%
- Cash to current liabilities
- 82.1%
Valuation
- P/E ratio
- –
- Price to sales
- 4.37
- Price to book
- 79.32
- Dividend yield
- –
See a number that looks wrong?